Apotex Pharmachem India

Bengaluru, India Founded: 2003 • Age: 23 yrs
Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care.

About Apotex Pharmachem India

Apotex Pharmachem India is a Healthcare company based in Bengaluru (India) founded in 2003. Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. It operates on a B2B model. The company has 136 employees. Apotex Pharmachem India has completed 1 acquisition, including CanPrev. Its focus areas include Pharmaceuticals, Drug Manufacturing and Generic and Biosimilar Medicines.

Company details

Apotex Pharmachem India, founded in 2003 in Bengaluru, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and generic and biosimilar medicines. Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

  • Headquarters Bengaluru, India
  • Employees 136
  • Sectors
    Healthcare
  • Website apotex.co.in
Key Metrics
  • Employee Count
    136
  • Investments & Acquisitions

Board of directors of Apotex Pharmachem India

The boards of the 2 registered companies of Apotex Pharmachem India currently have 6 directors; the longest-serving is Yoganjaneya Reddy Panem, appointed in 2015. 26 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Yoganjaneya Reddy Panem
DIN 02073863
Director09 Jun 201511 yrs 4 moApotex Pharmachem India Private Limited
Goutam Vilas Pujari
DIN 02891339
Director01 Dec 20187 yrs 10 moApotex Research Private Limited
Brian George Mcclelland
DIN 06568789
Director15 Sep 20233 yrs 1 moApotex Research Private Limited, Apotex Pharmachem India Private Limited
Kajal Palan
DIN 10546962
Additional Director03 May 20242 yrs 5 moApotex Pharmachem India Private Limited
Rajesh Salwan
DIN 07669286
Additional Director18 Mar 20251 yr 7 moApotex Research Private Limited
Uta Kellermann Renton
DIN 10993254
Additional Director18 Mar 20251 yr 7 moApotex Research Private Limited, Apotex Pharmachem India Private Limited

Financials of Apotex Pharmachem India

Figures of Apotex Research Private Limited, the primary company behind Apotex Pharmachem India, for FY 2025. Revenue was ₹727 Cr (+22% year on year). Net profit was ₹76.62 Cr (11% margin). EBITDA was ₹149 Cr (20% margin). Revenue has grown at a compounded annual rate of +10% over three years and +3% over five years.

  • ₹727 CrRevenue · FY 2025 · +22% YoY
  • ₹76.62 CrNet profit · 11% margin
  • ₹149 CrEBITDA · 20% margin
  • ₹292 CrPaid-up capital
  • 1,236Employees (provident fund records)
  • +10%Revenue CAGR, 3 years
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Apotex Research Private Limited are on its company page.

Premium access

Detailed financial statements for Apotex Pharmachem India

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Apotex Pharmachem India

Apotex Pharmachem India has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CanPrev.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Health Canada-licensed natural health products are manufactured in Canada.
canprev.comCanada0Feb 2025β€’β€’β€’β€’
Premium access

Complete acquisition details for Apotex Pharmachem India

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Apotex Pharmachem India

2 dated milestones of Apotex Pharmachem India across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Apotex Pharmachem India is founded.
  2. Acquisition Acquires CanPrev.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Apotex Pharmachem India

Apotex Pharmachem India was founded in 2003.

Apotex Pharmachem India is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Apotex Pharmachem India has 136 employees.

Apotex Pharmachem India, founded in 2003 in Bengaluru, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and generic and biosimilar medicines. Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Apotex Pharmachem India has made 1 acquisition, including CanPrev.

Apotex Pharmachem India is associated with 2 legal entities: Apotex Research Private Limited, Apotex Pharmachem India Private Limited.

The legal entities of Apotex Pharmachem India currently have 7 directors, including Brian George Mcclelland, Rajesh Salwan, Goutam Vilas Pujari and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available